BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9921987)

  • 21. Staging of renal cell carcinoma: cost-effectiveness of routine preoperative bone scans.
    Campbell RJ; Broaddus SB; Leadbetter GW
    Urology; 1985 Mar; 25(3):326-9. PubMed ID: 2983477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
    Lind P; Gallowitsch HJ
    Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
    Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J
    Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skeletal metastases from renal cell carcinoma: diagnostic uncertainty with molecular imaging.
    Revannasiddaiah S; Sood A; Thakur P; Sharma M
    BMJ Case Rep; 2012 Aug; 2012():. PubMed ID: 22922912
    [No Abstract]   [Full Text] [Related]  

  • 25. [Diagnostic value of whole-body MRI and bone scintigraphy in the detection of osseous metastases in patients with breast cancer--A Prospective Double-Blinded Study at two Hospital Centers].
    Ohlmann-Knafo S; Kirschbaum M; Fenzl G; Pickuth D
    Rofo; 2009 Mar; 181(3):255-63. PubMed ID: 19229791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
    Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
    J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone metastases of renal cell carcinoma: the role of surgery.
    Bickels J; Merimsky O
    Isr Med Assoc J; 2002 May; 4(5):376-8. PubMed ID: 12040831
    [No Abstract]   [Full Text] [Related]  

  • 28. [Uptake behavior of bone metastases of hypernephroma in the 99m Tc-MDP bone scintigram. A comparison with x-ray findings].
    Steinbächer M; Rieden K; Bihl H; Georgi P
    Rofo; 1987 May; 146(5):555-8. PubMed ID: 3035642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Distribution of bone metastases of cancers. A scintigraphic study of 376 cases].
    Bontoux D; Plazanet F; Azais I
    Bull Acad Natl Med; 1998; 182(5):997-1008; discussion 1008-9. PubMed ID: 9735503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastases.
    Tunn UW; Stenzl A; Schultze-Seemann W; Strauss A; Kindler M; Miller K; Wirth MP; Zantl N; Schulze M; May C; Ruebel A; Birkholz K; Gruenwald V
    Can J Urol; 2012 Jun; 19(3):6261-7. PubMed ID: 22704310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased renal retention of 99mTc-methylene diphosphonate after nephron-sparing surgery.
    Inoue Y; Ohtake T; Kameyama S; Yamazaki S; Kawabe K; Yoshikawa K; Nishikawa J; Sasaki Y
    J Nucl Med; 1999 Mar; 40(3):418-21. PubMed ID: 10086705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Patellar metastasis as an initial clinical-radiologic symptom of renal cell carcinoma].
    Weber J; Puschmann S; Freyschmidt J
    Rofo; 1999 Feb; 170(2):228-9. PubMed ID: 10101369
    [No Abstract]   [Full Text] [Related]  

  • 33. [Evaluation of bone metastases from renal cell carcinoma].
    Hoshi S; Orikasa S; Yoshikawa K; Metoki R; Tochigi T; Ono K; Saitoh S; Satoh M; Ohyama C; Suzuki K
    Nihon Hinyokika Gakkai Zasshi; 1991 Apr; 82(4):649-54. PubMed ID: 2051704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum gamma glutamyl-transferase is a sensitive but unspecific marker of metastatic renal cell carcinoma.
    Simic T; Dragicevic D; Savic-Radojevic A; Cimbaljevic S; Tulic C; Mimic-Oka J
    Int J Urol; 2007 Apr; 14(4):289-93. PubMed ID: 17470155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pathogenetic differentiation of the bone superscan using bone marrow scintigraphy].
    Weckesser M; Müller-Mattheis VG; Vosberg H; Müller-Gärtner HW
    Nuklearmedizin; 1998 Jun; 37(4):156-8. PubMed ID: 9650218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crossed fused renal ectopia with metastatic renal cell carcinoma.
    Siegel HJ; Casillas MA
    Clin Nucl Med; 2004 Nov; 29(11):765-6. PubMed ID: 15483508
    [No Abstract]   [Full Text] [Related]  

  • 37. Accumulation of iodine-131-iodocholesterol in renal cell carcinoma adrenal metastases.
    Tsukamoto E; Itoh K; Kanegae K; Kobayashi S; Koyanagi T; Tamaki N
    J Nucl Med; 1998 Apr; 39(4):656-8. PubMed ID: 9544676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zoledronic acid delays the onset of skeletal-related events and progression of skeletal disease in patients with advanced renal cell carcinoma.
    Lipton A; Zheng M; Seaman J
    Cancer; 2003 Sep; 98(5):962-9. PubMed ID: 12942563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of bone metastases from renal cell carcinoma].
    Tsuda S; Koga S; Nishikido M; Tsurusaki T; Igawa T; Noguchi M; Kanda S; Matsuya F; Kanetake H
    Hinyokika Kiyo; 2001 Mar; 47(3):155-8. PubMed ID: 11329954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical usefulness of 99mTc-PMT whole body scans in the diagnosis of bone metastases from hepatocellular carcinoma].
    Nakanishi Y; Ha-Kawa SK
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Feb; 52(2):208-16. PubMed ID: 1313962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.